| Literature DB >> 29318154 |
Murni Nazira Sarian1, Qamar Uddin Ahmed1, Siti Zaiton Mat So'ad1, Alhassan Muhammad Alhassan1, Suganya Murugesu1, Vikneswari Perumal1, Sharifah Nurul Akilah Syed Mohamad1, Alfi Khatib1, Jalifah Latip2.
Abstract
The best described pharmacological property of flavonoids is their capacity to act as potent antioxidant that has been reported to play an important role in the alleviation of diabetes mellitus. Flavonoids biochemical properties are structure dependent; however, they are yet to be thoroughly understood. Hence, the main aim of this work was to investigate the antioxidant and antidiabetic properties of some structurally related flavonoids to identify key positions responsible, their correlation, and the effect of methylation and acetylation on the same properties. Antioxidant potential was evaluated through dot blot, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, ABTS+ radical scavenging, ferric reducing antioxidant power (FRAP), and xanthine oxidase inhibitory (XOI) assays. Antidiabetic effect was investigated through α-glucosidase and dipeptidyl peptidase-4 (DPP-4) assays. Results showed that the total number and the configuration of hydroxyl groups played an important role in regulating antioxidant and antidiabetic properties in scavenging DPPH radical, ABTS+ radical, and FRAP assays and improved both α-glucosidase and DPP-4 activities. Presence of C-2-C-3 double bond and C-4 ketonic group are two essential structural features in the bioactivity of flavonoids especially for antidiabetic property. Methylation and acetylation of hydroxyl groups were found to diminish the in vitro antioxidant and antidiabetic properties of the flavonoids.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29318154 PMCID: PMC5727842 DOI: 10.1155/2017/8386065
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Basic structure of flavonoids consists of a fused A and C rings, with phenyl B ring attached through its 1′ position to the 2 position of the C ring.
Figure 2Relationship of hyperglycaemia, insulin resistance, and oxidative stress.
Figure 3Rapid screening of radical scavenging activity by dot blot assay on a silica sheet stained with a DPPH solution in MeOH at 16 different concentrations, namely, 1000, 500, 250, 125, 62.5, 31.25, 15.63, 7.81, 3.91, 1.95, 0.97, 0.488, 0.244, 0.122, 0.06, and 0.03 μg/mL applied from top to down. (A.A) ascorbic acid (positive control), (1) wogonin, (2) methyl ether (wogonin), (3) acetate (wogonin), (4) techtochrysin, (5) 8-hydroxy-7-methoxyflavone, (6) chrysin, (7) norwogonin, (8) acetate (norwogonin), (9) isoscutellarein, (10) hypolaetin, (11) kaempferol, (12) quercetin, (13) (+)-catechin, and (14) (−)-epicatechin.
IC50 values of flavonoids for DPPH, ABTS+, and xanthine oxidase inhibition assays.
| Samples ( | DPPH | ABTS+ | Xanthine oxidase |
|---|---|---|---|
| Ascorbic acid | 4.75 ± 0.91GHa | — | — |
| Trolox | — | 1.76 ± 0.15FG | — |
| Allopurinol | — | — | 0.16 ± 0.30D |
| Wogonin | >100B | 52.63 ± 2.99D | NA |
| Methyl ether (wogonin) | >200A | >200A | NA |
| Acetate (wogonin) | >200A | >200A | NA |
| Techtochrysin | >100B | 45.59 ± 4.75E | >100A |
| 8-Hydroxy-7-methoxyflavone | 68.24 ± 3.70C | 3.19 ± 0.15F | NA |
| Chrysin | >100B | >100B | >100A |
| Norwogonin | 35.61 ± 1.68D | 1.24 ± 0.19FG | NA |
| Acetate (norwogonin) | >100B | 78.99 ± 66.5C | NA |
| Isoscutellarein | 5.23 ± 0.53GHa | 1.73 ± 0.06FG | >100A |
| Hypolaetin | 3.69 ± 0.11Ha | 0.80 ± 0.03FG | >100A |
| Kaempferol | 10.89 ± 0.86EF | 1.36 ± 0.22FG | 16.36 ± 0.93B |
| Quercetin | 7.76 ± 0.99FG | 0.83 ± 0.01FG | 8.58 ± 0.72C |
| (+)-Catechin | 14.34 ± 1.55EF | 0.62 ± 0.05G | NA |
| (−)-Epicatechin | 9.92 ± 0.33F | 0.70 ± 0.08G | NA |
Values represent mean ± SEM (n = 3), NA: not active; capital letters represent Tukey's test, small letters represent Dunnett's test, and means not sharing a letter are significantly different (p < 0.05).
Result of FRAP in ascorbic acid equivalent (AAE).
| Samples | FRAP (AAE |
|---|---|
| Ascorbic acid | 114.58 ± 0.27Da |
| Wogonin | 39.15 ± 1.68E |
| Methyl-ether (wogonin) | 1.68 ± 0.18G |
| Acetate (wogonin) | 5.06 ± 3.24G |
| Techtochrysin | 11.49 ± 0.32F |
| 8-Hydroxy-7-methoxyflavone | 104.92 ± 8.29D |
| Chrysin | 21.38 ± 1.86F |
| Norwogonin | 152.14 ± 7.30C |
| Acetate (norwogonin) | 39.63 ± 1.01E |
| Isoscutellarein | 262.91 ± 4.99A |
| Hypolaetin | 177.37 ± 1.82B |
| Kaempferol | 265.65 ± 5.46A |
| Quercetin | 138.93 ± 6.22C |
| (+)-Catechin | 148.12 ± 4.40C |
| (−)-Epicatechin | 152.07 ± 1.95C |
Values represent mean ± SEM (n = 3), NA: not active; capital letters represent Tukey's test, small letters represent Dunnett's test, and means not sharing a letter are significantly different (p < 0.05).
IC50 values of flavonoids for α-glucosidase and DPP-4 inhibition assays.
| Samples |
| DPP-4 ( |
|---|---|---|
| Quercetin (commercial) | 4.30 ± 1.06Ea | — |
| Sitagliptin | — | 24.51 ± 1.01Da |
| Wogonin | >100A | >100A |
| Methyl ether (wogonin) | NA | >100A |
| Acetate (wogonin) | >100A | NA |
| Techtochrysin | >100A | >100A |
| 8-Hydroxy-7-methoxyflavone | >100A | >100A |
| Chrysin | >100A | NA |
| Norwogonin | >100A | >100A |
| Acetate (norwogonin) | NA | >100A |
| Isoscutellarein | 7.15 ± 0.96D | 22.23 ± 1.52Da |
| Hypolaetin | 48.42 ± 9.71B | 34.89 ± 7.44B |
| Kaempferol | 12.19 ± 4.63C | 45.93 ± 8.61B |
| Quercetin | 4.92 ± 7.06Ea | 21.75 ± 5.81Da |
| (+)-Catechin | NA | NA |
| (−)-Epicatechin | NA | NA |
Values represent mean ± SEM (n = 3), NA: not active; capital letters represent significant difference based on Tukey's test (p < 0.05) and small letters represent significant difference based on Dunnett's test (p < 0.05).
Figure 4Structure of the different classes of flavonoids.
Chemical structures and substituents of selected flavonoids.
| Class | Compound | Chemical structure | Substituents | |||||
|---|---|---|---|---|---|---|---|---|
| 3 | 5 | 7 | 8 | 3′ | 4′ | |||
| Flavone | Wogonin |
| H | OH | OH | OCH3 | H | H |
| Methyl ether (wogonin) |
| H | OCH3 | OCH3 | OCH3 | H | H | |
| Acetate (wogonin) |
| H | CH3COO | CH3COO | OCH3 | H | H | |
| Techtochrysin |
| H | OH | OCH3 | H | H | H | |
| 8-Hydroxy-7-methoxy flavone |
| H | H | OCH3 | OH | H | H | |
| Chrysin |
| H | OH | OH | H | H | H | |
| Norwogonin |
| H | OH | OH | OH | H | H | |
| Acetate (norwogonin) |
| H | CH3COO | CH3COO | CH3COO | H | H | |
| Isoscutellarein |
| H | OH | OH | OH | H | OH | |
| Hypolaetin |
| H | OH | OH | OH | OH | OH | |
|
| ||||||||
| Flavonol | Kaempferol |
| OH | OH | OH | H | H | OH |
| Quercetin |
| OH | OH | OH | H | OH | OH | |
|
| ||||||||
| Flavanol | (+)-Catechin (2 |
|
| OH | OH | H | OH | OH |
| (−)-Epicatechin (2 |
|
| OH | OH | H | OH | OH | |
Figure 5Summary of SAR study of antioxidant and antidiabetic effects of flavonoids.